Diabetes Fellowship Program

Diabetology Fellowship

Fellowship The Diabetes Fellowship Program is a vibrant one year program designed to prepare primary care physicians in diabetes management through extensive clinical training and research. This program is one of the few known programs nationally focusing on training primary care physicians in clinical diabetes care and research, and it is the only Diabetes Fellowship program at an osteopathic medical school.

Since the program began in 2004, all of its fellows have gone on to successful careers as diabetologists and have published articles in national peer review journals. Diabetes Fellows train and work alongside other diabetes related specialists including endocrinologists, cardiologists, nephrologists, podiatrists, ophthalmologists and wound care specialists. In addition, Fellows will participate in the following: weekly didactivs, scholaship to attend the ADA post graduate course and the ADA scientific session, and a one-week rotation at the Joslin Diabetes Center. At the completion of the Fellowship, physicians will have new expertise and insight to manage diabetes in a systematic manner and be will recognized as leaders in diabetes care.

Candidate selection is a competitive process and based on prior academic performance, a comprehensive interview process and recommendations from supervising faculty/attending physicians. Fellows receive an annual stipend, excellent benefit package and an assistant professor appointment at the Ohio University Heritage College of Osteopathic Medicine.

OHIO UNIVERSITY IS AN AFFIRMATIVE ACTION/EQUAL   OPPORTUNITY EMPLOYER
High Priority is placed on the creation of an environment   supportive of women, minorities and persons with disabilities.   We seek candidates with a commitment in working effectively   with students, faculty and staff from diverse backgrounds.

APPLY NOW

Fellowship FAQ's

1. How long is a fellowship?
A fellowship typically last one year from July ­1st ­to June 30th.

2. Where will I be working?
The fellowship work sites are at the Ohio University Heritage College of Osteopathic Medicine in Athens, Ohio, along with partnering hospitals in Athens, Ohio and Parkersburg, WV.

3. Who is eligible for the fellowship?
Fellows must be graduates of an AOA-/ACGME-approved residency in Family Medicine ­or ­Internal Medicine; BE board-certified/eligible in their primary specialty; must have Ohio licensure; and DEA licensure. D.O. and M.D. graduates are eligible.

4. How do I apply?
The application process is on-going. We are ­currently ­gearing ­up to take ­applications for the 2017-18 ­fellow­ position.  Applications will be available online at:  www.ohiouniversityjobs.com  ; Keyword: Diabetes.

5. What types of patients would I expect to encounter during the fellowship?
The fellowship provides an opportunity to see a diverse patient population in terms of age, gender and economic status. Patients are seen on an inpatient and outpatient basis.

6. Describe a typical week in the life of a fellow?
Fellows will spend about 60% of their time in a clinical care outpatient setting. Approximately 10-20% will be spent in their own specialty and 10-20% in a research and scholarly activity, and 5% will involve work with the Diabetes Free Clinic providing direct patient care and in hospital care.

7. What is it like to live in Athens, Ohio?
Athens is a small college town community located in the foothills of the Appalachian Mountains. It offers a wide variety of social, intellectual and recreational opportunities. http://www.athensohio.com/

Our Faculty

Healy Amber Healy, DO
Director of Diabetes Fellowship Program
Heritage College of Osteopathic Medicine
holdera@ohio.edu

 

Mezitis Nicholas H. E. Mezitis, MD
Associate Professor of Specialty Medicine
Department of Specialty Medicine
Heritage College of Osteopathic Medicine
740-593-0791
mezitis@ohio.edu


Guo Aili Guo, MD, PhD
Assistant Professor of Endocrinology
Department of Specialty Medicine
Heritage College of Osteopathic Medicine
740-597-9276
guoa@ohio.edu

Fellow Research

Guo with Student Research is a key component of the fellowship program. The Diabetes Fellows are expected to initiate an original research project related to the basic or clinical science of diabetes care management, and up to one day a week is dedicated to said research. Innovative and ground-breaking research projects are ongoing in numerous areas related to diabetes at the college and throughout other areas of the university. A list of publications co-authored by our fellows:

Immanuel Amissah, MD - 2016
Assessing Knowledge of Diabetes Mellitus and Management Practices among School Personnel in Southeastern Ohio School Districts - paper was submitted to the journal called the Diabetes Educator.

Novera Inam, MD - 2015
Nuzhat Un Nisa, MD - 2015

Prevalence of Sleep Apnea and Other Sleep Disorders in Poorly Controlled Type 1 Diabetes - IRB Approved.


Babak Baradar-Bokaie, MD – 2014

  • Marling, C., Bunescu, R., Baradar-Bokaie, B.,  Schwartz, F. Case-Based Reasoning as a Prelude to Big Data Analysis: A Case Study Workshop on Case-Based Reasoning in the Health Sciences at the International Conference on Case-Based Reasoning, which will be held in Frankfurt, Germany, on September 28, 2015.

Nancy Mora-Becerra, MD – 2013
Manganese supplementation effect on glycemic control on type 2 DM patients.

  • Shubrook JH, Mora NB, Adkins SE, Guo A. Insulin, A 2014 Primer: Part 1. Primary Care Reports 2014.20:8. 89-100.
  • Shubrook JH, Mora NB, Adkins SE, Guo A. Insulin, A 2014 Primer: Part 2. Primary Care Reports 2014.20:9. 101-112.
  • Millstein R, Mora Becerra N, Shubrook JH. Insulin pump therapy: Initiation and successful management. Cleveland Clinic Journal of Medicine. Accepted 2015 in press.
  • Mora, N., Ruberg, M.,  Nakazawa, M., Shubrook, J., Schwartz, F., Medically supervised fasting followed by low carb diet for extreme insulin resistance treatment in type 2 obese diabetic patients in a rural community outpatient practice (submitted to Clinical Endocrinology)

Gerard Sebastian, MD – 2013
Steroid-Induced hyperglycemia in the hospital and the effect of a novel insulin protocol.

  • Sebastian G, Shubrook JH. Use of U500 insulin in the outpatient setting. Abstract at the American Diabetes Association 74th Scientific Sessions, San Francisco CA. June 13-17.

Shagun Bindlish, MD – 2012
Lipodystrophy-A syndrome of severe insulin resistance.

  • Bindlish S, Shubrook JH. Complementary and Alternative Medicine in Diabetes. Submitted to Osteopathic Family Physician. December 2014.
  • Bindlish, S, Presswala, L, Schwartz, F: Lipodystrophy, syndrome of severe insulin resistance. Postgraduate Medicine, 2015. Feb (1-6).

Amber Healy, DO – 2012
Progesterone metabolism in women with polycystic ovarian syndrome.

  • Healy AM. Artificial Sweetners and High-fructose Corn Syrup: Effects on Diabetes and Weight. Integrative Medicine. 2013, 16(10): 114-119.
  • Healy AM, Schwartz FL. The role of socioeconomic stress in the risk for obesity and diabetes: potential new targets of treatment. Osteopathic Family Physician. 2010, 2(6): 180-186.
  • Healy, A, Ribacare, D, Benseler, J & Shubrook, JH. Disseminated Histoplasmosis in and 11 year old with type 1 diabetes. Pediatric On Call, 11(1), 23-24.

Richa Redhu, MD – 2011

  • Redhu-Gehlaut R, Shubrook JH. Revisiting Hypoglycemia. Osteopathic Family Physician 2014. 1:19-25.
  • Redhu Gehlaut R, Dogbey GW, Schwartz FL, Marling CR, Shubrook JH. Hypoglycemia in Type 2 Diabetes - More Common Than You Think: A Continuous Glucose Monitoring Study. Journal of Diabetes Science and Technology 2015. DOI: 10.1177/1932296815581052.

Cara O’Shaughnessey, DO – 2010

  • O'Shaughnessey, C. Safety and effects of exercise in older adults with Type 2 diabetes. AOA Health Watch, 2011; 14, 6 (3): 8-14.
  • O'Shaughnessey C, Shubrook JH. Hypoglycemia. Primary Care Reports 2012. 18(5):49-64.
  • O'Shaughnessey, C.,  Nelson, J., Schwartz F. Insulinoma, Osteopathic Family Physician 01/2012; 4(5):160–163.
  • Shubrook JH, O'Shaughnessey C. Hypoglycemia. Primary Care Reports. 2012;18(5):49-64.
  • O’ Shaughnessey CO, Colucci R, Schwartz FL, et Shubrook JH. Use of a Controlled Fast for the treatment of severe insulin resistance in patients with type 2 DM. Diabetes Science and Technology Meeting. April 2011.  Philadelphia PA.

Allison Petsnick, DO – 2009

  • Petznick AM, Shubrook JH. Treatment of specific macrovascular beds in patients with diabetes mellitus. Osteopath Med Prim Care. 2010 Aug 11; 4: 5. PMCID: PMC2925360.
  • Petznick A, Shubrook JH, Prevention and treatment of diabetes-related cardiovascular complications. Primary Care Reports. 2010, 16 (4):1-11.

Joseph Cook, DO – 2008

  • Szeles J, Cook J, Sammons D, Shubrook JH. Chronic Lesions on Legs. Journal of Family Practice 2011. 60;7:427-429. PMID: 21731921.

Randy Collucci, DO – 2007

  • Shubrook JH, Colucci RA, Schwartz FL. Exploration of the DPP-4 inhibitors with a focus on saxagliptin. Expert Opin Pharmacother. 2009 Dec; 10(17): 2927-2934.
  • Colucci RA, Silver MJ, Shubrook J. Common types of supraventricular tachycardia: Diagnosis and management. Am Fam Physician. 2010 Oct 15; 82(8): 942-952.
  • Shubrook JH, Colucci RA, Guo A, Schwartz, FL.  Saxagliptin: A selective DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. Clinical Medicine Insights: Endocrinology and Diabetes. 2011; (4) 1-12. PMID 22879789.
  • Colucci R. Bariatric surgery in patients with type 2 diabetes: A viable option. Postgraduate Medicine. 2011;123 (1):1-10. PMID: 21293081
  • Colucci, R, Jimenez, R, Malgore, R, Kohn, L, Schwartz, FL. Coexistence of Cushing’s Syndrome from a Functional Adrenal Adenoma and Addison’s Disease.  J American Osteopathic Assoc, 2012; 112(6):374-379.
  • O’ Shaughnessey CO, Colucci R, Schwartz FL, et Shubrook JH. Use of a Controlled Fast for the treatment of severe insulin resistance in patients with type 2 DM. Diabetes Science and Technology Meeting. April 2011.  Philadelphia PA.

Lee Bertheau, DO – 2006

  • Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F, Shubrook JH. Continuous glucose monitoring system in a rural intensive care unit: A pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol. 2010 May 1; 4(3): 636-644. PMCID: PMC2901041.
  • Shubrook JH, Bertheau, Thomas, Snow. “All or None Process and Outcomes Indicators of Diabetes Care in a National Sample of Resident Physicians.” To be presented at American Heart Association: Quality of Care and Outcomes Research in CV disease and Stroke Conference May 10-11, 2007.

Andrew Wapner, DO – 2005

  • Schwartz FL, Denham S, Heh V, Wapner A, Shubrook J. Experiences of children and adolescents with type 1 diabetes in school: Survey of children, parents, and schools. Diabetes Spectrum. 2010; 23(1): 47-55.

  • Wapner A, Bianco J, Long M, Kushnick M, Brannan G, Shubrook J. TAKE ACTION: A multidisciplinary lifestyle intervention for families in a rural community. Childhood Obesity. 2010; 6(5): 275-281.

  • Wapner, Denham, Shubrook JH, Schwartz. “Barriers to Diabetes Care of Children in School.” To be presented at American Diabetes Association 67th Scientific Sessions June 22-26, 2007.

  • Klein, Shubrook JH, Schwartz, Wapner. “The day of a diabetic: Time requirements for diabetes self-care”. To be presented at OU Research and Scholarly Creativity Fair and Ohio Osteopathic Association. June 21-24, 2007.

  • Wapner, A., Shubrook, JH., Schwartz, FL. Care of Children With Diabetes in School: A Survey of the Experiences of Children, Their Parents, and School Personnel Responsible For Their Care. 2007 ADA Scientific Session. Abstract # 0855P.